205 related articles for article (PubMed ID: 31559035)
41. Evaluation of the activated clotting time and activated partial thromboplastin time for the monitoring of heparin in adult extracorporeal membrane oxygenation patients.
Atallah S; Liebl M; Fitousis K; Bostan F; Masud F
Perfusion; 2014 Sep; 29(5):456-61. PubMed ID: 24570077
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of Anti-Activated Factor X Activity and Activated Partial Thromboplastin Time Relations and Their Association with Bleeding and Thrombosis during Veno-Arterial ECMO Support: A Retrospective Study.
Moussa MD; Soquet J; Lamer A; Labreuche J; Gantois G; Dupont A; Abou-Arab O; Rousse N; Liu V; Brandt C; Foulon V; Leroy G; Schurtz G; Jeanpierre E; Duhamel A; Susen S; Vincentelli A; Robin E
J Clin Med; 2021 May; 10(10):. PubMed ID: 34067573
[TBL] [Abstract][Full Text] [Related]
43. The role of nafamostat mesilate as a regional anticoagulant during extracorporeal membrane oxygenation.
Lee JH; Park JH; Jang JH; Kim SH; Hong SY; Heo W; Lee DH; Choi HS; Kim KH; Jang HJ
Acute Crit Care; 2022 May; 37(2):177-184. PubMed ID: 35545240
[TBL] [Abstract][Full Text] [Related]
44. A Randomized Controlled Trial of Antithrombin Supplementation During Extracorporeal Membrane Oxygenation.
Panigada M; Cucino A; Spinelli E; Occhipinti G; Panarello G; Novembrino C; Consonni D; Protti A; Lissoni A; Arcadipane A; Pesenti A; Grasselli G
Crit Care Med; 2020 Nov; 48(11):1636-1644. PubMed ID: 32947474
[TBL] [Abstract][Full Text] [Related]
45. Outcomes of heparinized adult veno-arterial extracorporeal membrane oxygenation patients managed with low and high activated partial thromboplastin time targets: A systematic review and meta-analysis.
Mazzeffi M; Lin D; Gonzalez-Almada A; Stombaugh DK; Curley J; Mangunta V; Teman N; Yarboro LT; Thiele R
Perfusion; 2024 Apr; 39(3):525-535. PubMed ID: 36595340
[TBL] [Abstract][Full Text] [Related]
46. Antithrombin restriction in extracorporeal membrane oxygenation support (ARES): A multidisciplinary approach.
Lam JC; Lam EH; Pidathala S; Padiyar JP
Perfusion; 2024 Jun; ():2676591241260179. PubMed ID: 38843822
[No Abstract] [Full Text] [Related]
47. Antithrombin during veno-venous extracorporeal membrane oxygenation with heparin anticoagulation: A single-center cohort study.
Hileman BA; Martucci G; Rizzitello N; Occhipinti G; Rossetti M; Tuzzolino F; Lorusso R; Panigada M; Tanaka K; Arcadipane A; Panarello G
Perfusion; 2024 Jun; ():2676591241258048. PubMed ID: 38833217
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of "Flat-Line" Thromboelastography During Extracorporeal Membrane Oxygenation for Respiratory Failure in Adults.
Panigada M; Iapichino G; L'Acqua C; Protti A; Cressoni M; Consonni D; Mietto C; Gattinoni L
ASAIO J; 2016; 62(3):302-9. PubMed ID: 26720739
[TBL] [Abstract][Full Text] [Related]
49. Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study.
Pieri M; Agracheva N; Bonaveglio E; Greco T; De Bonis M; Covello RD; Zangrillo A; Pappalardo F
J Cardiothorac Vasc Anesth; 2013 Feb; 27(1):30-4. PubMed ID: 23036625
[TBL] [Abstract][Full Text] [Related]
50. Measures of anticoagulation and coagulopathy in pediatric cardiac extracorporeal membrane oxygenation patients.
Yabrodi M; Ciccotello C; Bhatia AK; Davis J; Maher KO; Deshpande SR
Int J Artif Organs; 2022 Jan; 45(1):60-67. PubMed ID: 33372565
[TBL] [Abstract][Full Text] [Related]
51. Assessing Anticoagulation in Neonates With Congenital Diaphragmatic Hernia During Extracorporeal Membrane Oxygenation: Does Anti-Factor Xa or Thromboelastometry Provide Additional Benefit?
Perez Ortiz A; Dempfle CE; Jung T; Doniga T; Weiß C; Hetjens S; Schaible T; Rafat N
Front Pediatr; 2021; 9():685906. PubMed ID: 34604133
[No Abstract] [Full Text] [Related]
52. Risk factors for bleeding complications during venovenous extracorporeal membrane oxygenation as a bridge to recovery.
Kawauchi A; Liu K; Nakamura M; Suzuki H; Fujizuka K; Nakano M
Artif Organs; 2022 Sep; 46(9):1901-1911. PubMed ID: 35451086
[TBL] [Abstract][Full Text] [Related]
53. Anticoagulation Management during First Five Days of Infant-Pediatric Extracorporeal Life Support.
Bingham KR; Riley JB; Schears GJ
J Extra Corpor Technol; 2018 Mar; 50(1):30-37. PubMed ID: 29559752
[TBL] [Abstract][Full Text] [Related]
54. Comparison of bleeding and thrombotic outcomes in veno-venous extracorporeal membrane oxygenation: Heparin versus bivalirudin.
Kartika T; Mathews R; Migneco G; Bundy T; Kaempf AJ; Pfeffer M; DeLoughery TG; Moore K; Beardshear R; Oetken HJ; Case J; Hinds MT; McCarty OJT; Shatzel JJ; Zonies D; Zakhary B
Eur J Haematol; 2024 Apr; 112(4):566-576. PubMed ID: 38088062
[TBL] [Abstract][Full Text] [Related]
55. Extracorporeal lung support technologies - bridge to recovery and bridge to lung transplantation in adult patients: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(5):1-47. PubMed ID: 23074408
[TBL] [Abstract][Full Text] [Related]
56. Cost-effectiveness of Argatroban Versus Heparin Anticoagulation in Adult Extracorporeal Membrane Oxygenation Patients.
Cho AE; Jerguson K; Peterson J; Patel DV; Saberi AA
Hosp Pharm; 2021 Aug; 56(4):276-281. PubMed ID: 34381261
[No Abstract] [Full Text] [Related]
57. A comparison of low and standard anti-coagulation regimens in extracorporeal membrane oxygenation.
Raman J; Alimohamed M; Dobrilovic N; Lateef O; Aziz S
J Heart Lung Transplant; 2019 Apr; 38(4):433-439. PubMed ID: 30744940
[TBL] [Abstract][Full Text] [Related]
58. Efficacy and safety of argatroban in patients with acute respiratory distress syndrome and extracorporeal lung support.
Menk M; Briem P; Weiss B; Gassner M; Schwaiberger D; Goldmann A; Pille C; Weber-Carstens S
Ann Intensive Care; 2017 Dec; 7(1):82. PubMed ID: 28776204
[TBL] [Abstract][Full Text] [Related]
59. Outcomes following routine antithrombin III replacement during neonatal extracorporeal membrane oxygenation.
Stansfield BK; Wise L; Ham PB; Patel P; Parman M; Jin C; Mathur S; Harshfield G; Bhatia J
J Pediatr Surg; 2017 Apr; 52(4):609-613. PubMed ID: 27847121
[TBL] [Abstract][Full Text] [Related]
60. Is bivalirudin an alternative anticoagulant for extracorporeal membrane oxygenation (ECMO) patients? A systematic review and meta-analysis.
Li DH; Sun MW; Zhang JC; Zhang C; Deng L; Jiang H
Thromb Res; 2022 Feb; 210():53-62. PubMed ID: 35007937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
